浙贝母
Search documents
浙江绍兴市上虞区因地制宜发展林下经济:山林长出“绿色银行”
Ren Min Ri Bao· 2025-09-05 07:35
Core Viewpoint - The development of the under-forest economy in Chenxi Township, Shaoxing City, Zhejiang Province, is transforming local agricultural practices and enhancing community income through the cultivation of traditional Chinese medicinal herbs, particularly San Ye Qing and Huang Jing [1][2][3] Group 1: Economic Development - The establishment of a 10,000-acre traditional Chinese medicinal herb base in Chenxi Township aims to leverage local ecological advantages, with a focus on sustainable agricultural practices [1] - The "land bank + technical management + risk sharing" model allows for collective land investment and profit-sharing, ensuring stable income for local farmers [1] - The annual output value of the entire project is expected to exceed 10 million yuan, creating hundreds of job opportunities [2] Group 2: Community Impact - Villagers are experiencing significant income increases, with some reporting annual earnings of over 30,000 yuan from cultivating Huang Jing [2] - The initiative has led to the establishment of a complete industrial chain, from seedling cultivation to deep processing and health care applications [2] - The "green bank" concept is being realized as local economies benefit from the under-forest economy, with significant sales figures reported, such as over 2 million yuan in sales for Huang Jing products last year [2] Group 3: Policy Support - The "Thousand Villages, Ten Thousand Yuan" under-forest economic assistance program in Zhejiang Province encourages the development of local specialty industries, including medicinal herbs and edible fungi [3] - As of early this year, 500 under-forest economic assistance bases have been established across the province, covering over 150,000 acres and involving 1.07 million participants [3]
中药饮片质量问题频出,11项国家炮制规范草案细化质量标准
Xin Jing Bao· 2025-06-19 14:19
Core Viewpoint - The National Pharmacopoeia Commission has published 11 draft standards for the processing of traditional Chinese medicine (TCM) decoction pieces, addressing quality issues that have arisen this year due to frequent non-compliance in drug inspections [1][2]. Group 1: Draft Standards for TCM Decoction Pieces - The 11 draft standards cover various TCM decoction pieces including Banbianlian, Zisuye, Beishashen, Guanghuoxiang, Yimucao, Gaoliangjiang, Shudihuang, Shichangpu, Jingjie, Qicaotan, and Qicaoshan, specifying guidelines for processing, characteristics, and storage [2]. - For example, the processing standard for Banbianlian includes removing impurities, washing, cutting, drying, and sieving, while its characteristics and storage requirements are also detailed [2]. Group 2: Quality Inspection Reports - Multiple regions have reported non-compliance in TCM decoction pieces during drug quality inspections, with notable failures in Shanxi Province where 6 batches of decoction pieces were found non-compliant, involving well-known companies [3]. - In Jiangxi Province, 18 products were reported as non-compliant, including 11 batches of TCM materials and decoction pieces, with issues related to characteristics, identification, and microbial limits [4]. Group 3: Regulatory Actions and Expert Insights - Regulatory bodies are intensifying scrutiny on TCM decoction pieces, as evidenced by significant fines imposed on companies for producing substandard products, such as Anhui Baicui Jinfang Pharmaceutical Co., which faced penalties totaling 3.11 million yuan [4]. - Experts attribute the prevalence of substandard TCM decoction pieces to various factors, including the complexity of sourcing raw materials, lack of professional knowledge among suppliers, and the challenges of standardizing production practices [5][6].